Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

This study has been withdrawn prior to enrollment.

(determined not enough participants would be able to be enrolled and not enough data collected for good analyses)

Sponsor:

Information provided by (Responsible Party):

University of Arkansas

ClinicalTrials.gov Identifier:

NCT01464684

First received: October 31, 2011

Last updated: April 30, 2012

Last verified: April 2012

History of Changes

Purpose

Investigators will characterize the body composition and metabolism of infants born from lean, overweight or obese mothers from whom they had previously obtained a placenta and/or cord blood as part of the earlier placenta and cord blood study (#111576)

Condition
Infant Body Composition and Metabolism


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

Further study details as provided by University of Arkansas:

Biospecimen Retention: Samples With DNA

Blood, urine, and a cheek swab may be collected from study participants


Enrollment:	0
Study Start Date:	October 2011
Estimated Study Completion Date:	December 2012
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	3 Months to 21 Months
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

infants age 12 months (+/- 9 months)

Criteria

Inclusion Criteria:

mother's prior participation in study #111576 with successful collection of placenta
infant age 12 months (+/- 9 months)

Exclusion Criteria:

mother did not participate in study #111576
mother did participate in study #111576, but collection of placenta was not successful
infant not age 12 months (+/- 9 months)

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01464684

Sponsors and Collaborators

University of Arkansas

Investigators


Principal Investigator:	Aline Andres, PhD	University of Arkansas

More Information

No publications provided


Responsible Party:	University of Arkansas
ClinicalTrials.gov Identifier:	NCT01464684 History of Changes
Other Study ID Numbers:	132624
Study First Received:	October 31, 2011
Last Updated:	April 30, 2012
Health Authority:	United States: Food and Drug Administration

ClinicalTrials.gov processed this record on March 03, 2015

To Top